Cardlytics AI Stock Analysis
Want to see CDLX full AI Analyst Report?
Cardlytics (CDLX) AI Stock Analysis
Cardlytics
(NASDAQ:CDLX)
CDLX scores low primarily due to weak financial performance: shrinking TTM revenue, persistent losses, negative TTM operating/free cash flow, and especially a pressured balance sheet with negative equity. Technicals add caution with the stock below key longer-term moving averages and a negative MACD. The score is partially supported by earnings-call forward indicators (Q4 guidance for sequential billings growth and near-breakeven Adjusted EBITDA) and signs of margin/cost progress, but these improvements are not yet reflected in consistently positive profitability or cash generation.
Cardlytics (CDLX) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $8.72M
- Dividend Yield
- ―
- Average Volume (3M)
- 61.54K
- Price to Earnings (P/E)
- -0.2
- Beta (1Y)
- 2.36
- Revenue Growth
- -36.23%
- EPS Growth
- 57.24%
- Country
- US
- Employees
- 275
- Sector
- Communication Services
- Sector Strength
- 60
- Industry
- Advertising Agencies
Cardlytics Business Overview & Revenue Model
Company Description
Cardlytics, Inc. provides an advertising platform, operating in both the United States and the United Kingdom. Among its key offerings is the Cardlytics platform, a proprietary advertising channel integrated directly into banks' digital environments....
How the Company Makes Money
Cardlytics makes money primarily by selling advertising and marketing services to brands (marketers) that want to reach consumers and drive incremental purchases. Its core revenue model is tied to campaigns that leverage transaction data and bank dis...
Cardlytics Earnings Call Summary
The call presented a mixed outlook. Q3 financial performance was weak, with billings, revenue, Adjusted Contribution, Adjusted EBITDA, and MQUs down year-over-year, alongside a U.K. bank disruption and advertiser budget pressure. However, management highlighted strong new-business growth, advertiser retention, expanding CRP partnerships, technology and AI initiatives, improved contribution margin and Free Cash Flow, and guidance for 10%-20% sequential billings growth in Q4. The positive strategic and forward-looking developments broadly balanced the significant Q3 declines.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For Q4 2026, Cardlytics expects billings between $63 million and $69 million, revenue between $35 million and $39 million, Adjusted Contribution between $20 million and $23 million, and Adjusted EBITDA between negative $1 million and positive $2 million; the guidance represents 10%-20% growth in billings quarter-over-quarter and a return to sequential growth, and the company expects to return to sequential growth in Q4.
Cardlytics Financial Statement Overview
Summary
Overall financial quality is weak. TTM revenue declined sharply (-10.7%), profitability remains negative (operating and net losses), and TTM operating cash flow and free cash flow are negative. The biggest risk is the balance sheet: negative equity in 2025 and TTM with elevated leverage reduces financial flexibility despite some narrowing of losses versus prior years.
Income Statement
26NegativeBalance Sheet
18Very NegativeCash Flow
24Negative| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 160.18M | 233.27M | 278.30M | 309.20M | 298.54M | 267.12M |
| Gross Profit | 77.89M | 105.08M | 120.89M | 130.38M | 112.63M | 103.34M |
| EBITDA | -3.69M | -65.45M | -152.53M | -99.00M | -420.41M | -88.21M |
| Net Income | -36.55M | -103.49M | -189.30M | -134.70M | -465.26M | -128.56M |
Balance Sheet | ||||||
| Total Assets | 228.51M | 285.64M | 392.71M | 574.14M | 691.24M | 1.26B |
| Cash, Cash Equivalents and Short-Term Investments | 29.95M | 48.72M | 65.59M | 91.83M | 121.91M | 233.47M |
| Total Debt | 174.81M | 215.31M | 221.65M | 266.11M | 235.26M | 197.23M |
| Total Liabilities | 251.54M | 292.15M | 322.72M | 439.35M | 479.63M | 573.10M |
| Stockholders Equity | 0 | -6.51M | 69.99M | 134.80M | 211.60M | 690.70M |
Cash Flow | ||||||
| Free Cash Flow | -13.71M | -6.49M | -28.12M | -12.58M | -67.39M | -51.09M |
| Operating Cash Flow | -7.13M | 9.29M | -8.82M | -185.00K | -53.90M | -38.52M |
| Investing Cash Flow | 14.17M | -15.30M | -18.75M | -10.06M | -15.76M | -506.69M |
| Financing Cash Flow | -21.15M | -11.12M | 1.44M | -20.03M | -39.99M | 486.00M |
Cardlytics Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CDLX, the sentiment is Negative. The current price of 1.43 is below the 20-day moving average (MA) of 1.83, below the 50-day MA of 2.63, and below the 200-day MA of 5.75, indicating a bearish trend. The MACD of -0.24 indicates Negative momentum. The RSI at 29.74 is Positive, neither overbought nor oversold. The STOCH value of 4.67 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for CDLX.
Cardlytics Risk Analysis
Cardlytics disclosed 57 risk factors in its most recent earnings report. Cardlytics reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksCardlytics Peers Comparison
Overall Rating
QNST81Outperform
CRTO68Neutral
ZD60Neutral- CDLX44Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| QNST | 81Outperform | $1.11B | 11.70 | 29.48% | ― | 29.46% | 785.72% |
| CRTO | 68Neutral | $863.71M | 12.35 | 6.34% | ― | -7.49% | -54.94% |
| Sector * | 60Neutral | $48.67B | 4.58 | -11.27% | 4.14% | 2.83% | -41.78% |
| ZD | 60Neutral | $1.70B | 3.06 | 31.54% | ― | -14.20% | -164.26% |
| CDLX | 44Neutral | $10.07M | -0.22 | 551.43% | ― | -36.23% | 57.24% |
* Communication Services Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| CDLX | Cardlytics, Inc. | 1.43 | -12.47 | -89.71% | |
| ZD | Ziff Davis, Inc. | 51.69 | 21.34 | 70.31% | |
| QNST | Quinstreet | 19.12 | 5.27 | 38.05% | |
| CRTO | Criteo S.A. | 17.43 | -3.34 | -16.08% |
Cardlytics Corporate Events
Cardlytics Settles Bridg-Related Indemnification Dispute Agreement
NeutralCardlytics has disclosed the resolution of a legal dispute stemming from indemnification obligations it assumed in its 2021 acquisition of Bridg, Inc., involving founder and former Bridg CEO Amit Jain. Jain had sought advancement and indemnification...
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 06, 2026